Pharmacogenetics of Cardiovascular Prevention in Diabetes: From Precision Medicine to Identification of Novel Targets

Pharmacogenetics—a branch of precision medicine—holds the promise of becoming a novel tool to reduce the social and healthcare burdens of cardiovascular disease (CVD) and coronary artery disease (CAD) in diabetes. The improvement in cardiovascular risk stratification resulting from adding genetic ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Morieri, Mario Luca, Pipino, Caterina, Doria, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504677/
https://www.ncbi.nlm.nih.gov/pubmed/36143187
http://dx.doi.org/10.3390/jpm12091402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504677/
https://www.ncbi.nlm.nih.gov/pubmed/36143187
http://dx.doi.org/10.3390/jpm12091402

Ejemplares similares